Pharma major, Wanbury's net profit has grown 5.62 times at Rs 9.48 crore in Q1FY10 as against Rs 1.43 crore in the year-ago period.
Its net sales at Rs 83.74 crore in the reporting quarter rose 25.6 per cent as against Rs 66.66 crore in the year-ago period, a press release issued here today said.
EBITDA margin for Q1FY10 was at 19.60 per cent as against 16.40 per cent in Q1FY09.
Wanbury has registered a compounded annual growth rate of 68 per cent over the last 6-years and has a strong presence in domestic formulations, active pharmaceutical ingredients and contract research and manufacturing services (CRAMS), the release said.
